Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma

Anesthesiology

Volumn 117, Issue 3, 2012, Pages 580-591

  Serra, Magda F ^a   Anjos Valotta, Edna A ^a   Olsen, Priscilla C ^a   Couto, Gina C ^a   Jurgilas, Patricia B ^a   Cotias, Amanda C ^a   Pão, Camila R ^a   Ferreira, Tatiana P T ^a   Arantes, Ana C S ^a   Pires, Ana L A ^a   Cordeiro, Renato S B ^a   Silva, Patricia M R ^a   Martins, Marco A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; EOTAXIN; GELATINASE B; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LIDOCAINE; OVALBUMIN; TRANSCRIPTION FACTOR GATA 3;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANESTHETICS, LOCAL; ANIMALS; ASTHMA; BRONCHI; DISEASE MODELS, ANIMAL; FIBROSIS; GATA3 TRANSCRIPTION FACTOR; LIDOCAINE; LUNG; MALE; MATRIX METALLOPROTEINASE 9; MICE; MUCUS; NEBULIZERS AND VAPORIZERS; T-LYMPHOCYTES;

EID: 84865583344     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31826687d5     Document Type: Article

References (44)

1. Lemanske RF Jr, Busse WW: Asthma: Clinical expression and molecular mechanisms. J Allergy Clin Immunol 2010; 125: S95-102
2. Shalaby KH, Martin JG: Overview of asthma; the place of the T cell. Curr Opin Pharmacol 2010; 10:218-25
3. Barnes PJ: Glucocorticosteroids: Current and future directions. Br J Pharmacol 2011; 163:29-43
4. Walsh ER, Stokes K, August A: The role of eosinophils in allergic airway inflammation. Discov Med 2010; 9:357-62
5. Bai TR: Evidence for airway remodeling in chronic asthma. Curr Opin Allergy Clin Immunol 2010; 10:82-6
6. Holgate ST, Holloway J, Wilson S, Howarth PH, Haitchi HM, Babu S, Davies DE: Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol 2006; 117:496-506
7. Mauad T, Dolhnikoff M: Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008; 14:31-8
8. Lai HY, Rogers DF: Mucus hypersecretion in asthma: Intra-cellular signalling pathways as targets for pharmacotherapy. Curr Opin Allergy Clin Immunol 2010; 10:67-76
9. Dewachter P, Mouton-Faivre C, Emala CW, Beloucif S: Case scenario: Bronchospasm during anesthetic induction. ANESTHESIOLOGY 2011; 114:1200-10
10. Groeben H, Grosswendt T, Silvanus MT, Pavlakovic G, Peters J: Airway anesthesia alone does not explain attenuation of histamine-induced bronchospasm by local anesthetics: A comparison of lidocaine, ropivacaine, and dyclonine. ANESTHESIOLOGY 2001; 94: 423-8
11. Wang W, Li JJ, Foster PS, Hansbro PM, Yang M: Potential therapeutic targets for steroid-resistant asthma. Curr Drug Targets 2010; 11:957-70
12. Barnes PJ: Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010; 120: 76-85
13. Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF: Steroid resistance in asthma: Mechanisms and treatment options. Curr Allergy Asthma Rep 2008; 8:171-8
14. Ohnishi T, Kita H, Mayeno AN, Okada S, Sur S, Broide DH, Gleich GJ: Lidocaine in bronchoalveolar lavage fluid (BALF) is an inhibitor of eosinophil-active cytokines. Clin Exp Immunol 1996; 104:325-31
15. Hunt LW, Swedlund HA, Gleich GJ: Effect of nebulized lido-caine on severe glucocorticoid-dependent asthma. Mayo Clin Proc 1996; 71:361-8
16. Decco ML, Neeno TA, Hunt LW, O'Connell EJ, Yunginger JW, Sachs MI: Nebulized lidocaine in the treatment of severe asthma in children: A pilot study. Ann Allergy Asthma Immunol 1999; 82:29-32
17. Rosario NA, Riedi CA, Farias L: Lidocaine nebulization for treatment of asthma. Ann Allergy Asthma Immunol 2000; 85:245-6
18. Hunt LW, Frigas E, Butterfield JH, Kita H, Blomgren J, Dunnette SL, Offord KP, Gleich GJ: Treatment of asthma with nebulized lido-caine: A randomized, placebo-controlled study. J Allergy Clin Immunol 2004; 113:853-9
19. Saito K, Sato N, Shimono N, Hagiwara K, Kanazawa M, Nagata M: A pregnant woman with severe asthma effectively treated by inhalational lidocaine therapy. Nihon Kokyuki Gakkai Zasshi 2006; 44:828-32
20. Abuan T, Yeager M, Montgomery AB: Inhaled lidocaine for the treatment of asthma: Lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies. J Aerosol Med Pulm Drug Deliv 2010; 23:381-8
21. da Costa JC, Olsen PC, de Azeredo Siqueira R, de Frias Carvalho V, Serra MF, Alves LA, Faria RX, Xisto DG, Rocco PR, Cordeiro RS, Rodrigues E Silva PM, Martins MA: JMF2-1, a lidocaine derivative acting on airways spasm and lung allergic inflammation in rats. J Allergy Clin Immunol 2007; 119:219-25
22. Muraki M, Iwanaga T, Haraguchi R, Kubo H, Tohda Y: Continued inhalation of lidocaine suppresses antigen-induced airway hyper-reactivity and airway inflammation in ovalbumin-sensitized guinea pigs. Int Immunopharmacol 2008; 8:725-31
23. Shinagawa K, Kojima M: Mouse model of airway remodeling: Strain differences. Am J Respir Crit Care Med 2003; 168: 959-67
24. Olsen PC, Ferreira TP, Serra MF, Farias-Filho FA, Fonseca BP, Viola JP, Cordeiro RS, Silva PM, Costa JC, Martins MA: Lido-caine-derivative JMF2-1 prevents ovalbumin-induced airway inflammation by regulating the function and survival of T cells. Clin Exp Allergy 2011; 41:250-9
25. Llewellyn BD: An improved Sirius red method for amyloid. J Med Lab Technol 1970; 27:308-9
26. Meyerholz DK, Griffin MA, Castilow EM, Varga SM: Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model. Toxi-col Pathol 2009; 37:249-55
27. Prado CM, Leick-Maldonado EA, Kasahara DI, Capelozzi VL, Martins MA, Tibério IF: Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. Am J Physiol Lung Cell Mol Physiol 2005; 289:L677-83
28. Youn CJ, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, McElwain K, McElwain S, Raz E, Broide DH: Immunostimulatory DNA reverses established allergen-induced airway remodeling. J Immunol 2004; 173:7556-64
29. Makowski GS, Ramsby ML: Calibrating gelatin zymograms with human gelatinase standards. Anal Biochem 1996; 236: 353-6
30. Okada S, Hagan JB, Kato M, Bankers-Fulbright JL, Hunt LW, Gleich GJ, Kita H: Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 1998; 160:4010-7
31. Bankers-Fulbright JL, Kephart GM, Loegering DA, Bradford AL, Okada S, Kita H, Gleich GJ: Sulfonylureas inhibit cyto-kine-induced eosinophil survival and activation. J Immunol 1998; 160:5546-53
32. Ohbayashi H, Shimokata K: Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy 2005; 4:177-81
33. Walsh ER, Sahu N, Kearley J, Benjamin E, Kang BH, Humbles A, August A: Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med 2008; 205:1285-92
34. Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, Colbert DC, Lee NA, Lee JJ: Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 2008; 205:699-710
35. Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA: Eosinophils in health and disease: The LIAR hypothesis. Clin Exp Allergy 2010; 40:563-75
36. Kariyawasam HH, Robinson DS: The role of eosinophils in airway tissue remodelling in asthma. Curr Opin Immunol 2007; 19:681-6
37. Lee NA, Gelfand EW, Lee JJ: Pulmonary T cells and eosinophils: Coconspirators or independent triggers of allergic respiratory pathology? J Allergy Clin Immunol 2001; 107:945-57
38. Alcorn JF, Crowe CR, Kolls JK: TH17 cells in asthma and COPD. Annu Rev Physiol 2010; 72:495-516
39. Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89:587-96
40. Erpenbeck VJ, Hohlfeld JM, Discher M, Krentel H, Hagenberg A, Braun A, Krug N: Increased messenger RNA expression of c-maf and GATA-3 after segmental allergen challenge in allergic asthmatics. Chest 2003; 123:370S-1S
41. Lahat A, Ben-Horin S, Lang A, Fudim E, Picard O, Chowers Y: Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation. Clin Exp Immunol 2008; 152:320-7
42. Costa JC, Neves JS, de Souza MV, Siqueira RA, Romeiro NC, Boechat N, e Silva PM, Martins MA: Synthesis and antispasmodic activity of lidocaine derivatives endowed with reduced local anesthetic action. Bioorg Med Chem Lett 2008; 18:1162-6
43. Olsen PC, Coelho LP, da Costa JC, Cordeiro RS, Silva PM, Martins MA: Two for one: Cyclic AMP mediates the anti-inflammatory and anti-spasmodic properties of the non-anesthetic lidocaine analog JMF2-1. Eur J Pharmacol 2012; 680:102-7
44. Tanaka A, Minoguchi K, Oda N, Yokoe T, Matsuo H, Okada S, Tasaki T, Adachi M: Inhibitory effect of lidocaine on T cells from patients with allergic asthma. J Allergy Clin Immunol 2002; 109:485-90